Actionable exomic incidental findings in 6503 participants: challenges of variant classification

…, DR Metterville, M Kelly, AKM Foreman… - Genome …, 2015 - genome.cshlp.org
Recommendations for laboratories to report incidental findings from genomic tests have
stimulated interest in such results. In order to investigate the criteria and processes for assigning …

[HTML][HTML] Prenatal exome sequencing in anomalous fetuses: new opportunities and challenges

…, N Strande, E Hardisty, K Gilmore, AKM Foreman… - Genetics in …, 2017 - Elsevier
Purpose We investigated the diagnostic and clinical performance of exome sequencing in
fetuses with sonographic abnormalities with normal karyotype and microarray and, in some …

[PDF][PDF] Genomic sequencing for newborn screening: results of the NC NEXUS project

…, SB Crowley, MI Roche, AKM Foreman… - The American Journal of …, 2020 - cell.com
Newborn screening (NBS) was established as a public health program in the 1960s and is
crucial for facilitating detection of certain medical conditions in which early intervention can …

[PDF][PDF] Variant classification concordance using the ACMG-AMP variant interpretation guidelines across nine genomic implementation research studies

…, MO Dorschner, C Driscoll, AKM Foreman… - The American Journal of …, 2020 - cell.com
Harmonization of variant pathogenicity classification across laboratories is important for
advancing clinical genomics. The two CLIA-accredited Electronic Medical Record and Genomics …

A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencing

JS Berg, AKM Foreman, JM O'daniel, JK Booker… - Genetics in …, 2016 - nature.com
Purpose: As genome-scale sequencing is increasingly applied in clinical scenarios, a wide
variety of genomic findings will be discovered as secondary or incidental findings, and there …

[HTML][HTML] An approach to integrating exome sequencing for fetal structural anomalies into clinical practice

…, L Ramkissoon, E Hardisty, AKM Foreman… - Genetics in …, 2020 - Elsevier
Purpose We investigated the diagnostic and clinical performance of trio exome sequencing (ES)
in parent–fetus trios where the fetus had sonographic abnormalities but normal …

An age-based framework for evaluating genome-scale sequencing results in newborn screening

…, DM DeCristo, SB Crowley, AKM Foreman… - The Journal of …, 2019 - Elsevier
Objective To assess the performance of a standardized, age-based metric for scoring clinical
actionability to evaluate conditions for inclusion in newborn screening and compare it with …

Actionability of commercial laboratory sequencing panels for newborn screening and the importance of transparency for parental decision-making

DM DeCristo, LV Milko, JM O'Daniel, AKM Foreman… - Genome Medicine, 2021 - Springer
Background Newborn screening aims to identify individual patients who could benefit from
early management, treatment, and/or surveillance practices. As sequencing technologies …

A review and definition of 'usual care'in genetic counseling trials to standardize use in research

…, KE Donohue, KM East, AKM Foreman… - Journal of genetic …, 2021 - Wiley Online Library
The descriptor ‘usual care’ refers to standard or routine care. Yet, no formal definition exists.
The need to define what constitutes usual care arises in clinical research. Often one arm in a …

[HTML][HTML] The who, what, and why of research participants' intentions to request a broad range of secondary findings in a diagnostic genomic sequencing study

…, JS Berg, BC Powell, G Corbie-Smith, AKM Foreman… - Genetics in …, 2018 - Elsevier
… Powell MD, PhD 6 , Giselle Corbie-Smith MD, MSc 7 8 9 , Ann Katherine M. Foreman MS,
CGC 4 6 , Ida Griesemer BA 10 , Kristy Lee MS, CGC 6 , Julianne M. O’Daniel MS, CGC 4 6 , …